Results 201 to 210 of about 390,786 (264)
Perforated colorectal cancer (PCC) is considered to have a poor prognosis; however, it remains unclear whether this is attributable to perforation itself or to perforation‐related clinicopathological factors. In this study, we analyzed prognosis using propensity score matching with perforation‐related factors and demonstrated that perforation is an ...
Yoshiaki Fujii +8 more
wiley +1 more source
Examining the effectiveness of follow-up chemotherapy in large cell neuroendocrine carcinoma: special emphasis on stage T1-2N0M0 according to 9<sup>th</sup> edition TNM guidelines. [PDF]
Pan H, Zhang Y, Ying M, Zhai C.
europepmc +1 more source
Abdominoperineal resection (APR) after minimally invasive rectal cancer surgery was associated with significantly higher rates of erectile and early ejaculatory dysfunction compared with anal‐sparing surgery. Although ejaculatory function showed partial recovery over time, erectile dysfunction persisted up to 12 months postoperatively.
Taiki Kajiwara +14 more
wiley +1 more source
A Phase III study of perioperative dostarlimab in patients with dMMR/MSI-H resectable colon cancer: AZUR-2 study design. [PDF]
Starling N +14 more
europepmc +1 more source
GLIM‐defined malnutrition probably worsens overall survival in patients with gastroenterological cancer after surgery. ABSTRACT Background In cancer patients, malnutrition worsens postoperative outcomes, with increased complications and poor prognosis.
Ryota Matsui +4 more
wiley +1 more source
Adjuvant radiotherapy for FIGO 2023 stage IC endometrial carcinoma. [PDF]
Kahvecioğlu A +9 more
europepmc +1 more source
This systematic review and meta‐analysis of 38 studies, encompassing over 5000 patients, compared extralevator abdominoperineal excision (ELAPE) with standard abdominoperineal excision (APE) in patients with advanced low rectal cancer. ELAPE was associated with significantly improved overall and disease‐free survival, reduced intraoperative perforation
Sarolta Beáta Kávási +7 more
wiley +1 more source
Concerned issues and controversies in perioperative immunotherapy for resectable non-small cell lung cancer. [PDF]
Liu J, Ren Q, Cai Y, Chen D, Wu X, Xu W.
europepmc +1 more source

